Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors

With the aim of evaluating the specific pattern of in vitro antibody production (IVAP) in human immunodeficiency virus type 1 (HIV-1)-infected long-term non-progressors (LTNPs), we tested 20 subjects who had remained asymptomatic for more than 8 years with a CD4+ cell count higher than 500/microlite...

Full description

Saved in:
Bibliographic Details
Published inClinical immunology and immunopathology Vol. 85; no. 3; pp. 320 - 323
Main Authors RUSCONI, S, BERLUSCONI, A, PAPAGNO, L, COLOMBO, M. C, DE MADDALENA, C, RIVA, A, BAGNARELLI, P, BALOTTA, C, GALLI, M
Format Journal Article
LanguageEnglish
Published San Diego, CA Academic Press 01.12.1997
New York, NY
Boston
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:With the aim of evaluating the specific pattern of in vitro antibody production (IVAP) in human immunodeficiency virus type 1 (HIV-1)-infected long-term non-progressors (LTNPs), we tested 20 subjects who had remained asymptomatic for more than 8 years with a CD4+ cell count higher than 500/microliter and 59 patients at different stages of HIV-1 infection as controls. In cell cultures, IVAP was detected in 14 out of 20 LTNPs (70%), in 5 out of 6 recent seroconverters (83%), and in all the other control patients. Anti-p24 antibody production was significantly lower in LTNPs than in asymptomatic patients with a more recent infection. Recent seroconverters and patients with AIDS did not produce anti-p24 antibodies (P = 0.02). Anti-gp160 antibodies were produced by peripheral blood mononuclear cells from LTNPs in 12/20 cases. CD4+ cell count was significantly higher in IVAP-negative than in IVAP-positive LTNPs (P = 0.013), while the viral load was not significantly different. Specific anti-HIV-1 antibody production did not seem to be a correlate of long-term nonprogression.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0090-1229
1090-2341
DOI:10.1006/clin.1997.4470